As we've mentioned all year long, this is and will continue to be a busy year for headline IPO's. So far has not been a disappointment. Last week saw major price fluctuations in recent IPO's like Uber (NYSE: UBER), and BeyondMeats (NASDAQ: BYND) which nearly hit a $6 billion market cap. We also had a very successful IPO from what was labeled the Chinese Starbucks rival, Luckin Coffee (NASDAQ: LK). They were able to raise $561 million in their IPO which gained 20% in its first day. There were three other smaller IPO's that also had positive first day performance.
This week sort of starts a temporary, two week pause for the IPO markets but there are still a four names to take a look at. The bulk of the money raised this week is looking like it will be from one name.
Rattler Midstream (NASDAQ: RTLR) is another oil services company that is a large spin off from Diamondback Energy (NASDAQ: FANG). The company will offer 33 million shares at a range of $16 -$19.
The three other names this week are in the biotech space and include two Phase 1 biotechs and one Phase 2. Peloton Therapeutics (NASDAQ: PLTX) is focused on kidney cancer and is currently in phase 2 medical trials for this medication. They will be offering 9.3 million shares at a range of $15 - $17 in hopes of raising $150 million.
Also in the cancer space is IDEAYA Biosciences (NASDAQ: IDYA) which is a Phase 1 trial name that will be offering 5 million shares at a range of $13 - $15.
Finally, out of the UK we have Bicycle Therapeutics (NASDAQ: BCYC) which is focused on precision cancer medications based on peptides that they seem to have named themselves after. They will offer 4.3 million shares at a range of $14 -$16.